Plain-English translation of NCT07255859 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new home-based monitoring system called AVIGA that uses your computer's camera to track your eye movements and detect early signs of vision problems in people with age-related macular degeneration (AMD). Instead of traveling to the clinic for frequent checkups, you would use this portable system at home to monitor your central vision. The study will compare how well this new home system works compared to the standard paper-based vision monitoring tool (Amsler grid) that patients typically use.
People with AMD require frequent clinic visits for eye injections and monitoring, which puts stress on both eye clinics and patients. By allowing patients to monitor their eyes safely at home using the new treatment, this study aims to reduce unnecessary hospital visits while catching vision problems early.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to monitor your eyes using either the AVIGA home system or the standard Amsler grid tool. If assigned to AVIGA, you would use the system at home on your computer to take brief, self-administered eye tests at regular intervals—the system tracks your eye movements to detect any changes in your central vision. You would also continue with standard clinical care as needed. The study team will compare how well each monitoring method detects early signs of vision problems and assess the overall cost-effectiveness of the home-based approach.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Singapore